---
layout: default
title: Farhana Islam
description: Curriculum Vitae
---

## Education

| **Doctor of Philosophy (Ph.D.)**, Pharmacology   | Department of Pharmacology & Toxicology,<br />_University of Toronto, Toronto, ON._ |
| **Master of Science (M.Sc.)**, Neuroscience      | Centre for Neuroscience Studies,<br />_Queen’s University, Kingston, ON._           |
| **Bachelor of Science (Honours) (H.B.Sc.)**,<br />Neuroscience and Biochemistry majors, Psychology minor | University of Toronto - St. George Campus, Toronto, ON


* * *

## Publications

**Islam, F.**, Marshe, V.S., Magarbeh, L., Frey, B.N., Milev, R.V., Soares, C., Parikh, S., Placenza, F., Strother, S.C., Hassel, S., Taylor, V.H., Leri, F., Blier, P., Uher, R., Farzan, F., Lam, R.W., Turecki, G., Foster, J.A., Rotzinger, S., Kennedy, S.H., Müller, D.J. (2022) [Effects of CYP2C19 and CYP2D6 Gene Variants on Escitalopram and Aripiprazole Treatment Outcome and Serum Levels: Results from the CAN-BIND 1 Study](https://www.nature.com/articles/s41398-022-02124-4). Translational Psychiatry. 12, 366.

**Islam, F.**, Hain, D., Lewis, D., Law, R., Brown, L., Tanner, J-A., & Müller, D.J. (2022) [Pharmacogenetics of Clozapine-induced Agranulocytosis: A Systematic Review and Meta-Analysis](https://www.nature.com/articles/s41397-022-00281-9). The Pharmacogenomics Journal. DOI: 10.1038/s41397-022-00281-9

**Islam, F.**, Men, X., Yoshida, K., Zai, C.C., & Müller, D.J. (2021) [Pharmacogenetics-guided advances in antipsychotic treatment](https://pubmed.ncbi.nlm.nih.gov/34129738/). Clinical Pharmacology and Therapeutics. 110(3), 582-588.

**Islam, F.**, Gorbovskaya, I., & Müller, D.J. (2021) [Pharmacogenetic/Pharmacogenomic Tests for Treatment Prediction in Depression. In: Kim YK. (eds) Major Depressive Disorder](https://pubmed.ncbi.nlm.nih.gov/33834403/). Advances in Experimental Medicine and Biology, vol 1305. Springer, Singapore. 

**Islam, F.**, Maciukiewicz, M., Freeman, N., Eric, H., Tiwari, A., Mulsant, B.H., Pollock, B.G., Remington, G., Kennedy, J.L, Müller, D.J., & Rajji, TK. (2021) [Contributions of Cholinergic Receptor Muscarinic 1 (CHRM1) and CYP1A2 Gene Variants on the Effects of Plasma Ratio of Clozapine/N-Desmethylclozapine on Working Memory in Schizophrenia](https://pubmed.ncbi.nlm.nih.gov/33143542/). Journal of Psychopharmacology. 35(1), 31-39.

Marshe, V.S., Maciukiewicz, M., Hauschild, A-C., **Islam, F.**, Qin, L., Tiwari, A.K., Sibille, E., Blumberger, D.M., Karp, J.F., Flint, A.J., Kennedy, S.H., Lam, R.W., Frey, B., CAN-BIND Investigator Team, Kennedy, J.L., Mulsant, B.H., Reynolds III, C.F., Lenze, E.J., & Müller, D.J. (2021) [Genome-wide analysis suggests the importance of vascular processes and neuroinflammation in late-life antidepressant response](https://www.nature.com/articles/s41398-021-01248-3). Translational Psychiatry. 11(1), 1-12. 

Marshe, V.S., **Islam, F.**, Maciukiewicz, M., Fiori, L.M., Yerko, V., Yang, J., Turecki, G., Foster, J.A., Kennedy, S.H., Blumberger, D.M., Karp, J.F., Kennedy, J.L., Muslant, B.H., Reynolds, C.F. 3rd, Lenze, E.J., & Müller, D.J. (2020) [Validation study of microRNAs previously associated with antidepressant response in older adults treated for late-life depression with venlafaxine](https://pubmed.ncbi.nlm.nih.gov/31954757/). Progress in Neuro-Psychopharmacology & Biological Psychiatry. 100, 109867.

Marshe, V.S., **Islam, F.**, Maciukiewicz, M., Bousman, C., Eyre, H.A., Lavretsky, H., Muslant, B.H., Reynolds, C.F. 3rd, Lenze, E.J., & Müller, D.J. (2020) [Pharmacogenetic Implications for Antidepressant Pharmacotherapy in Late-Life Depression: A Systematic Review of the Literature for Response, Pharmacokinetics and Adverse Drug Reactions](https://pubmed.ncbi.nlm.nih.gov/32122803/). American Journal of Geriatric Psychiatry. 28(6), 609.

**Islam, F.**, Voineskos, A., Mulsant, B.H., & Rajji, TK. [Expression of brain derived neurotrophic factor in individuals with schizophrenia and healthy aging: testing the accelerated aging hypothesis in schizophrenia](https://pubmed.ncbi.nlm.nih.gov/28534294/). (2017) Current Psychiatry Reports. 19 (7), 36.

**Islam, F.**, Xu, K., & Beninger, R.J. [Inhibition of Wnt signalling dose-dependently impairs the acquisition and expression of amphetamine-induced conditioned place preference](https://pubmed.ncbi.nlm.nih.gov/28284949/). (2017) Behavioural Brain Research. 326, 217-225.

* * *

## Selected Honours and Awards


2017, 2022.       | Department of Pharmacology & Toxicology Book Fund Travel Award, _University of Toronto_
2021	            | Early Career Investigator Award for the 2021 World Congress of Psychiatric Genetics (WCPG), _International Society of Psychiatric Genetics (ISPG)_
2021, 2020, 2018	| Ontario Graduate Scholarship (3x), _Ministry of Colleges and Universities_
2019, 2017, 2016	| University of Toronto Fellowship (3x), _University of Toronto_
2019	            | Catherall Travel Bursary, _Massey College, University of Toronto_
2017, 2018	      | Massey College Junior Fellowship (2x), _Massey College, University of Toronto_
2017	            | Pharmacology Graduate Student Award, _University of Toronto_
2017	            | Frist-Jus Annual Memorial Award in Neuropsychopharmacology, _University of Toronto_
2014, 2015	      | Clifton Foundation Scholarship (2x), _Pathways to Education_
2014, 2015	      | Queen’s Graduate Award (2x), _School of Graduate Studies, Queen’s University_


* * *

## Teaching Experiences

2017-Present<br />Teaching Assistant, _University of Toronto_<br /> 

* Biostatistics I (CHL5201Y), _Dalla Lana School of Public Health_ 
* Biometrics (BIO360H), _Department of Biology at the Mississauga Campus_ 
* Pharmacology and Toxicology in Society (PCL389H), _Department of Pharmacology and Toxicology_ 
* Personalized Medicine (PHM360H), _Department of Pharmacy_

2014-2017<br />Teaching Assistant, _Queen's University_<br /> 

* Abnormal Psychology (PSYC 235), _Department of Psychology_ 
* Social Psychology (PSYC 241), _Department of Psychology_


* * *

## Professional Development

Sept 2020      | Machine Learning, _Canadian Bioinformatics Workshop, Virtual_            | Workshop on machine learning and its application to bioinformatics: Decision Trees and Random Forests, Artificial Neural Networks (ANNs), and Hidden Markov Models (HMMs).<br /> [Certificate](https://drive.google.com/file/d/1nybmlzAISLhkSkE9pKz-31lj5WfJuQXX/view)
August 2018   | Towards Pharmacogenomics in Clinic, _U-PGx Summer School, Bonn, Germany_  | Summer school on the fundamentals of pharmacogenomics and its applications

* * *

## Service and Outreach

2022 - Present                  | Appointed Member            | University of Toronto Tribunal, _University of Toronto_
2022 - Present                  | Elected Member              | Board of Directors, _University of Toronto Graduate Students' Union_
2021 - Present                  | Committee Member            | PGx Psychiatry Special Interest Group, _Pharmacogenomics Research Network (PGRN)_
2020 - Present                  | Graduate Ambassador for Department of Pharmacology & Toxicology | Faculty of Medicine, _University of Toronto_
2018                            | Protégée of City Councillor Lucy Troisi of Ward 28    |   _City of Toronto_
2017                            | Mentee of Senator Salma Ataullahjan                   | Women in House, _University of Toronto_


* * *

## Activism


2022 - Present;<br />2018-2019  | Appointed Member (2 terms)                            | University Affairs Board, Office of the Governing Council, _University of Toronto_ |

|* Represented students directly to the University in considering policy of a non-academic nature and matters that directly concern the quality of student and campus life.
* Advocated for university policies that reflect the needs of students for inclusive and accessible non-academic services.|


2021 - Present                  | President (previously Vice President - elected)       | Tenants’ Association, _University Family Housing, University of Toronto_ | 

|* Advocate on behalf of residents living at UFH directly to building management to resolve collective issues and improve living conditions for students and their families.|


2020 - Present                  | Committee Member                                        | Equity, Diversity and Inclusion (EDI) Committee, _Canadian College of Neuropsychopharmacology (CCNP)_ | 

|* Serve as a Member of the EDI committee for the CCNP actively working to create a more inclusive College where there is equal opportunity for and treatment of all meeting participants and staff.|


2020 - 2021                  | Student Advisor                                             | Housing Services Student Advisory Committee, _Student Life, University of Toronto_ | 

|* Provide input and feedback on matters pertaining to housing services, programming for students, resources and departmental budget priorities.
* Advocate for affordable housing options for students and their families on campus.|

2019 - 2020                  | Internal Liason Officer (elected)                            | Executive Committee, _CUPE 3902_ | 

|* Served as the Local’s representative in collaborations with student and labour unions and equity-seeking groups within the University community.
* Developed allyship with members and non-members in preparation for bargaining as part of the Political Action Committee.
* Managed the Local’s representatives on Joint Health and Safety Committees.
* Advocated for marginalised voices and ensured the Local prioritises the needs of members for inclusive and accessible workplaces.|

2016 - 2020                  | President (2018-2020) and Vice President (2017-2018) (Elected) | Race and Ethnicity Caucus, _University of Toronto Graduate Students’ Union (UTGSU)_ | 

|* Committed to social justice, community building, and healing for self-identified racialized graduate students at the university.
* Organized events, campaigns and initiatives, and collaborated with various on-campus groups to bring awareness to issues that affect BIPOC communities.|

2018 - 2020                  | Board Member                                                   | Student Initiative Fund (SIF), _Student Life, University of Toronto_ | 

|* Involved in the selection of student-led projects and initiatives that enhance the student experience and foster a sense of community at the university.|


* * *

## Professional Memberships

2021 - Present                  | Member            | American Society for Clinical Pharmacology and Therapeutics (ASCPT)
2019 - Present                  | Junior Member     |  Canadian College of Neuropsychopharmacology (CCNP)
2019 - Present                  | Member            |  Pharmacogenomics Research Network (PGRN)

* * *

## Conference Presentations

# Symposium

**Islam, F.**, Marshe, V.S., .., S., Kennedy, S.H., Müller, D.J. Association of CYP2C19 and CYP2D6 genotypes and plasma levels of escitalopram and aripiprazole with treatment outcome in the CAN-BIND-1 sample. Talk presented at symposium: Moving Depression Pharmacogenetics Forward-Using Scientific Discoveries to Inform Clinical Decisions at the _World Congress of Psychiatry Genetics (WCPG)_, 12 October 2021; Virtual.

# Posters

**Islam, F.**, Magarbeh, L, .., S., Kennedy, S.H., Müller, D.J. . [Effects of CYP2C19, CYP2D6, and ABCB1 gene variants on escitalopram and aripiprazole treatment-related sexual side effects: results from the CAN-BIND-1 study](https://www.researchgate.net/publication/363833088_EFFECTS_OF_CYP2C19_CYP2D6_AND_ABCB1_GENE_VARIANTS_ON_ESCITALOPRAM_AND_ARIPIPRAZOLE_TREATMENT-RELATED_SEXUAL_SIDE_EFFECTS_RESULTS_FROM_THE_CAN-BIND-1_STUDY). _World Congress of Psychiatry Genetics (WCPG)_, 15 September 2022; Florence, Italy.

**Islam, F.**, Hain, D., Lewis, D., Law, R., Brown, L., Tanner, J-A., & Müller, D.J. [Genetic Determinants of Clozapine-Induced Agranulocytosis: A Systematic Review and Meta-Analysis](https://www.biologicalpsychiatryjournal.com/article/S0006-3223(21)00955-0/fulltext). Poster at the 76th Annual Meeting of the _Society of Biological Psychiatry_, 30 April 2021; Virtual.

**Islam, F.**, Maciukiewicz, M., Freeman, N., Eric, H., Tiwari, A., Mulsant, B.H., Pollock, B.G., Remington, G., Kennedy, J.L, Müller, D.J., & Rajji, TK. [Contributions of Cholinergic Receptor Muscarinic 1 (CHRM1) and CYP1A2 Gene Variants on the Effects of Plasma Ratio of Clozapine/N-Desmethylclozapine on Working Memory in Schizophrenia](https://pubmed.ncbi.nlm.nih.gov/33143542/). Poster at the _World Congress of Psychiatry Genetics (WCPG)_, 20 October 2020; Virtual.

**Islam, F.**, Maciukiewicz, M., Freeman, N., Eric, H., Tiwari, A., Mulsant, B.H., Pollock, B.G., Remington, G., Kennedy, J.L, Müller, D.J., & Rajji, TK. [Contributions of Cholinergic Receptor Muscarinic 1 (CHRM1) and CYP1A2 Gene Variants on the Effects of Plasma Ratio of Clozapine/N-Desmethylclozapine on Working Memory in Schizophrenia](https://journals.sagepub.com/doi/full/10.1177/0269881120946288). Poster at the 75th Annual Meeting of the _Society of Biological Psychiatry_, 30 April 2020; New York City, NY. Conference cancelled.

**Islam, F.**, Maciukiewicz, M., Freeman, N., Eric, H., Tiwari, A., Mulsant, B.H., Pollock, B.G., Remington, G., Kennedy, J.L, Müller, D.J., & Rajji, TK. Effects of CYP1A2 and Cholinergic Receptor Muscarinic 1 (CHRM1) Gene Polymorphisms on Plasma Ratio of Clozapine/N-desmethylclozapine and Working Memory Performance in Schizophrenia. Poster presented at the _Canadian College of Neuropsychopharmacology 2019 Annual Meeting_, 14 June 2019; Montreal, QC.

**Islam, F.**, Marshe, V.S., Maciukiewicz, A., Lam, R., MacQueen, G., Frey, B., Milev, R., Parikh, S., Soares, C., Uher, R., Turecki, G., Rotzinger, S., Foster, J., Kennedy, S.H., Müller, D.J. Association of CYP2C19 and CYP2D6 genotypes and plasma levels of escitalopram and aripiprazole with treatment outcome in the CAN-BIND-1 sample. Poster presented at the Pharmacogenetic Research Network Meeting at the _American Society for Human Genetics_ Annual Meeting, 17 October 2019; Houston, TX.

**Islam, F.**, Marshe, V.S., Maciukiewicz, M., Lisoway, A., Lam, R., MacQueen, G., Frey, B., Milev, R., Parikh, S., Soares, C., Uher, R., Turecki, G., Rotzinger, S., Foster, J., Kennedy, S.H., Müller, D.J. Effects of CYP2C19 and CYP2D6 gene polymorphisms and methylation on plasma levels of escitalopram and aripiprazole and treatment outcome in the CAN-BIND-1 sample. Poster presented at the _Clinical Pharmacogenetics Implementation Consortium (CPIC®) Meeting_, 6 June 2019; Memphis, TN.

**Islam, F.**, Marshe, V.S., Maciukiewicz, M., Lam, R., MacQueen, G., Frey, B., Milev, R., Parikh, S., Soares, C., Uher, R., Turecki, G., Rotzinger, S., Foster, J., Kennedy, S.H., Müller, D.J. Association of CYP2C19 and CYP2D6 genotypes and plasma levels of escitalopram and aripiprazole with treatment outcome in the CAN-BIND-1 sample. Poster presented at the _World Federation of Societies of Biological Psychiatry (WFSBP)_ 14th World Congress of Biological Psychiatry, 5 June 2019; Vancouver, BC.

**Islam, F.**, Marshe, V.S., Maciukiewicz, M., Yoshida, K., Lam, R., MacQueen, G., Frey, B., Milev, R., Parikh, S., Soares, C., Uher, R., Turecki, G., Rotzinger, S., Foster, J., Kennedy, S.H., Müller, D.J. Impact of CYP2C19 and CYP2D6 Genotypes on Clinical Outcomes and Side Effects in Patients Receiving Escitalopram and Aripiprazole for Major Depression: Results From the CAN-BIND Cohort. Poster presented at the 74th Annual Meeting of the _Society of Biological Psychiatry_, 18 May 2019; Chicago, IL.

Yoshida, K., **Islam, F.**, Marshe, V.S., Maciukiewicz, M., Lam, R., MacQueen, G., Frey, B., Milev, R., Parikh, S., Soares, C., Uher, R., Turecki, G., Rotzinger, S., Foster, J., Kennedy, S.H., Müller, D.J. Impact of CYP2C19 and CYP2D6 Genotypes on Clinical Outcomes and Side Effects in Patients Receiving Escitalopram and Aripiprazole for Major Depression: Results From the CAN-BIND Cohort. Poster presented at the 57th Annual Meeting of the _American College of Neuropsychopharmacology_, 10 December 2018, Orlando, FL.

**Islam, F.**, Xu, K., and Beninger, R.J. Inhibition of Wnt signalling dosedependently impairs the acquisition and expression of amphetamine induced conditioned place preference. Poster presented at the _Society for Neuroscience_; 14 Nov 2016; San Diego, CA.

**Islam, F.**, and Beninger, R.J. Wnt inhibitor, IWP2, impairs expression of amphetamine produced conditioned place preference in rats. Poster presented at: 10th Annual CAN Meeting, _Canadian Association for Neuroscience_; 1 Jun 2016; Toronto, ON.




[back](./)
